PCN44 - FIRST-LINE TREATMENT EFFICACY IN EGFR-POSITIVE NON-SMALL CELL LUNG CANCER: A NETWORK META-ANALYSIS
PCN44 - FIRST-LINE TREATMENT EFFICACY IN EGFR-POSITIVE NON-SMALL CELL LUNG CANCER: A NETWORK META-ANALYSIS is a paper indexed in ScholarIQ from OpenAlex.
How many citations does PCN44 - FIRST-LINE TREATMENT EFFICACY IN EGFR-POSITIVE NON-SMALL CELL LUNG CANCER: A NETWORK META-ANALYSIS have?
PCN44 - FIRST-LINE TREATMENT EFFICACY IN EGFR-POSITIVE NON-SMALL CELL LUNG CANCER: A NETWORK META-ANALYSIS has 0 citations in the OpenAlex counts ScholarIQ stores.
When was PCN44 - FIRST-LINE TREATMENT EFFICACY IN EGFR-POSITIVE NON-SMALL CELL LUNG CANCER: A NETWORK META-ANALYSIS published?
PCN44 - FIRST-LINE TREATMENT EFFICACY IN EGFR-POSITIVE NON-SMALL CELL LUNG CANCER: A NETWORK META-ANALYSIS has 2018 year in the ScholarIQ index.
What is the open-access status of PCN44 - FIRST-LINE TREATMENT EFFICACY IN EGFR-POSITIVE NON-SMALL CELL LUNG CANCER: A NETWORK META-ANALYSIS?
PCN44 - FIRST-LINE TREATMENT EFFICACY IN EGFR-POSITIVE NON-SMALL CELL LUNG CANCER: A NETWORK META-ANALYSIS has closed oa status in the ScholarIQ index.
What is the DOI of PCN44 - FIRST-LINE TREATMENT EFFICACY IN EGFR-POSITIVE NON-SMALL CELL LUNG CANCER: A NETWORK META-ANALYSIS?
The DOI for PCN44 - FIRST-LINE TREATMENT EFFICACY IN EGFR-POSITIVE NON-SMALL CELL LUNG CANCER: A NETWORK META-ANALYSIS is on the source record.
What is the OpenAlex record for PCN44 - FIRST-LINE TREATMENT EFFICACY IN EGFR-POSITIVE NON-SMALL CELL LUNG CANCER: A NETWORK META-ANALYSIS?
The OpenAlex for PCN44 - FIRST-LINE TREATMENT EFFICACY IN EGFR-POSITIVE NON-SMALL CELL LUNG CANCER: A NETWORK META-ANALYSIS is on the source record.